The functional characterization of ILEI to be a cytokine involved inepithelial/mesenchymal transition and the identification of biologicallyactive ILEI provides the basis for generating ILEI inhibitors, in particularanti-ILEI antibodies, that are useful in the therapy of cancer, fibrosis andCOPD.